Quick Answer
Celularity Inc reported Cash And Cash Equivalents At Carrying Value of $738.0 thousand for the year ending 2024.
- Celularity Inc showed an increase of +225.1% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
- This data is from Celularity Inc's annual report (Form 10-K), filed with the SEC on May 8, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $9.5 thousand | Q1 2019: $18.9 thousand | Q2 2019: $1.17 million | Q3 2019: $1.02 million | Q4 2019: $917.0 thousand | Q1 2020: $504.9 thousand | Q2 2020: $716.7 thousand | Q3 2020: $454.5 thousand | Q1 2021: $28.7 thousand | Q2 2021: $211.00 | Q3 2021: $72.72 million | Q1 2022: $48.04 million | Q2 2022: $38.00 million | Q3 2022: $42.65 million | Q1 2023: $8.53 million | Q2 2023: $3.08 million | Q3 2023: $273.0 thousand | Q1 2024: $1.90 million | Q2 2024: $467.0 thousand | Q3 2024: $133.0 thousand | Q4 2024: $738.0 thousand | Q1 2025: $293.0 thousand | Q2 2025: $863.0 thousand | Q3 2025: $120.0 thousand.
- Over the full 7 years of available data (2018 to 2024), Celularity Inc's Cash And Cash Equivalents At Carrying Value has grown by 2,887.0%.
- Historical annual values: Fiscal year 2024: $738.0 thousand | Fiscal year 2023: $227.0 thousand | Fiscal year 2022: $13.97 million | Fiscal year 2021: $37.24 million | Fiscal year 2020: $54.31 million | Fiscal year 2019: $917.0 thousand | Fiscal year 2018: $24.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: